MedPath

PHENERGAN EXPECTORANT SYR

PHENERGAN EXPECTORANT SYR

Discontinued
DIN Number

01937553

Drug Class

Human

Market Date

Dec 31, 1993

Company
HC

rhone-poulenc rorer consumer inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01937553
AIG Number0211789001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R05CA10 COMBINATIONS
Product Specifications
Dosage FormSyrup
Route of AdministrationOral
AHFS Classification48:16.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

POTASSIUM GUAIACOL SULPHONATEActive
Strength: 40 MG / ML
Monograph: POTASSIUM GUAIACOL SULPHONATE
PROMETHAZINE HYDROCHLORIDEActive
Strength: 5.65 MG / ML
Monograph: PROMETHAZINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.